StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
3595
This month
47
This week
12
This year
348
Yesterday
1
Publishing Date
2024 - 04 - 16
4
2024 - 04 - 15
5
2024 - 04 - 11
5
2024 - 04 - 09
3
2024 - 04 - 05
4
2024 - 04 - 04
4
2024 - 04 - 03
6
2024 - 04 - 02
3
2024 - 04 - 01
5
2024 - 03 - 28
3
2024 - 03 - 27
3
2024 - 03 - 26
6
2024 - 03 - 25
7
2024 - 03 - 22
5
2024 - 03 - 21
6
2024 - 03 - 20
5
2024 - 03 - 19
4
2024 - 03 - 18
5
2024 - 03 - 15
9
2024 - 03 - 14
7
2024 - 03 - 13
5
2024 - 03 - 11
13
2024 - 03 - 08
5
2024 - 03 - 05
6
2024 - 03 - 04
11
2024 - 03 - 01
5
2024 - 02 - 29
6
2024 - 02 - 28
4
2024 - 02 - 27
8
2024 - 02 - 23
7
2024 - 02 - 22
3
2024 - 02 - 21
4
2024 - 02 - 20
9
2024 - 02 - 16
4
2024 - 02 - 15
4
2024 - 02 - 13
9
2024 - 02 - 12
10
2024 - 02 - 09
3
2024 - 02 - 06
4
2024 - 02 - 05
5
2024 - 02 - 02
4
2024 - 02 - 01
6
2024 - 01 - 31
6
2024 - 01 - 30
4
2024 - 01 - 29
3
2024 - 01 - 25
5
2024 - 01 - 24
6
2024 - 01 - 23
7
2024 - 01 - 22
5
2024 - 01 - 18
3
2024 - 01 - 17
2
2024 - 01 - 16
5
2024 - 01 - 15
2
2024 - 01 - 11
2
2024 - 01 - 09
7
2024 - 01 - 08
10
2024 - 01 - 05
3
2024 - 01 - 04
6
2024 - 01 - 03
6
2024 - 01 - 02
5
Sector
Communications
3
Consumer non-durables
2
Electronic technology
3
Finance
2
Health services
2
Health technology
267
Manufacturing
25
N/a
16
Producer manufacturing
1
Professional, scientific, and technical services
4
Retail trade
1
Technology services
2
Wholesale trade
1
Tags
Acquisition
687
Advanced
218
Agreement
489
America
217
Biopharma
226
Business
917
Cancer
350
Ceo
302
Companies
245
Company
515
Conference
2498
Corporation
794
Deadline
504
Distribution
228
Earnings
245
Energy
704
Events
293
Fda
348
Financial
3138
First
1699
For
677
Global
1513
Grants
246
Group
789
Growth
1008
Health
455
International
390
Key
397
Life
250
Management
383
Market
2674
Medical
378
Meeting
558
Million
1224
N/a
28384
Nasdaq
533
Offering
650
One
248
Partnership
310
Pharma
222
Pharmaceuticals
588
Platform
281
Program
422
Reach
492
Report
1914
Research
833
Results
4326
Revenue
276
Services
401
Set
325
Solutions
426
Spac
230
Study
356
System
286
Technology
611
Therapeutics
1191
Treatment
441
Trial
440
Update
906
Year
2879
Entities
2seventy bio, inc.
2
3d systems corporation
1
4d molecular therapeutics inc
1
60 degrees pharmaceuticals, inc.
2
Abbott laboratories
43
Abbvie inc.
1
Akebia therapeutics, inc.
2
Amneal pharmaceuticals, inc.
2
Applied therapeutics, inc.
2
Beigene, ltd.
2
Better therapeutics inc
2
Boston scientific corporation
3
Brainstorm cell therapeutics inc.
2
Bristol-myers squibb company
3
Cabaletta bio, inc.
3
Camden property trust
2
Candel therapeutics inc
2
Clearpoint neuro inc.
3
Cybin inc
2
Danaher corporation
2
Eli lilly and company
3
Ensysce biosciences inc
2
Eyenovia, inc.
3
Fortress biotech, inc.
3
Geron corporation
2
Inhibikase therapeutics, inc.
3
Invivyd inc
2
Ionis pharmaceuticals, inc.
2
Iovance biotherapeutics, inc.
3
Johnson & johnson
70
Journey medical corp
2
Lipella pharmaceuticals inc
2
Lisata therapeutics inc
2
Mangoceuticals, inc.
2
Nurix therapeutics, inc.
3
Nuwellis inc
2
Orange
3
Pepgen inc.
2
Perrigo company
40
Petros pharmaceuticals inc
2
Pfizer, inc.
2
Regeneron pharmaceuticals, inc.
7
Sanofi
51
Scilex holding company
2
Seastar medical holding corp
2
Sellas life sciences group, inc.
2
Simulations plus, inc.
2
Solid biosciences inc.
2
Soligenix, inc.
3
T2 biosystems, inc.
3
Takeda pharmaceutical company limited
3
Theratechnologies inc.
4
Tonix pharmaceuticals holding corp.
5
United health products, inc.
2
Urogen pharma ltd.
2
Vanda pharmaceuticals inc.
5
Verrica pharmaceuticals inc.
2
Vertex pharmaceuticals incorporated
2
Veru inc.
2
Zevra therapeutics, inc.
2
Symbols
ABBV
1
ABT
43
AKBA
2
AMRX
2
APLT
2
BCLI
2
BEIGF
2
BGNE
2
BMY
3
BSX
3
BTTX
2
CABA
3
CADL
2
CLPT
3
CPT
2
CYBN
2
DERM
2
DHR
2
ENSC
2
EYEN
3
FBIO
3
FNCTF
3
GERN
2
ICU
2
IKT
3
IONS
2
IOVA
3
IVVD
2
JNJ
70
LIPO
2
LLY
3
LSTA
2
MGRX
2
NRIX
3
NUWE
2
PEPG
2
PFE
2
PRGO
40
PTPI
2
REGN
7
SCLX
2
SLDB
2
SLP
2
SLS
2
SNGX
3
SNY
51
SNYNF
51
SXTP
2
TAK
3
THTX
4
TNXP
5
TSVT
2
TTOO
3
UEEC
2
URGN
2
VERU
2
VNDA
5
VRCA
2
VRTX
2
ZVRA
2
Exchanges
Amex
5
Nasdaq
281
Nyse
112
Crawled Date
2024 - 04 - 16
4
2024 - 04 - 15
5
2024 - 04 - 11
5
2024 - 04 - 09
3
2024 - 04 - 05
4
2024 - 04 - 04
4
2024 - 04 - 03
6
2024 - 04 - 02
3
2024 - 04 - 01
6
2024 - 03 - 28
3
2024 - 03 - 27
3
2024 - 03 - 26
6
2024 - 03 - 25
7
2024 - 03 - 22
5
2024 - 03 - 21
6
2024 - 03 - 20
5
2024 - 03 - 19
4
2024 - 03 - 18
5
2024 - 03 - 15
9
2024 - 03 - 14
7
2024 - 03 - 13
5
2024 - 03 - 11
13
2024 - 03 - 08
5
2024 - 03 - 05
6
2024 - 03 - 04
11
2024 - 03 - 01
5
2024 - 02 - 29
6
2024 - 02 - 28
4
2024 - 02 - 27
8
2024 - 02 - 23
7
2024 - 02 - 22
3
2024 - 02 - 21
5
2024 - 02 - 20
8
2024 - 02 - 16
4
2024 - 02 - 15
4
2024 - 02 - 13
8
2024 - 02 - 12
10
2024 - 02 - 09
3
2024 - 02 - 06
4
2024 - 02 - 05
5
2024 - 02 - 02
4
2024 - 02 - 01
6
2024 - 01 - 31
6
2024 - 01 - 30
4
2024 - 01 - 29
3
2024 - 01 - 25
5
2024 - 01 - 24
6
2024 - 01 - 23
7
2024 - 01 - 22
5
2024 - 01 - 19
3
2024 - 01 - 17
2
2024 - 01 - 16
5
2024 - 01 - 15
2
2024 - 01 - 11
2
2024 - 01 - 09
8
2024 - 01 - 08
9
2024 - 01 - 05
3
2024 - 01 - 04
6
2024 - 01 - 03
6
2024 - 01 - 02
5
Crawled Time
00:00
6
01:00
3
02:00
1
04:20
1
05:00
4
06:00
5
07:00
2
08:00
2
10:00
3
11:00
12
12:00
49
12:30
29
13:00
52
13:30
25
14:00
16
14:30
20
15:00
20
15:30
10
16:00
6
16:20
1
17:00
14
18:00
3
19:00
8
20:00
15
21:00
17
22:00
2
23:00
22
Source
bridgebio.com
1
spacfeed.com
2
www.biospace.com
152
www.fda.gov
3
www.globenewswire.com
155
www.prnewswire.com
35
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
published :
This year
tags :
Fda
save search
FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies
Published:
2024-04-19
(Crawled : 12:00)
- biospace.com/
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
2.04%
|
O:
0.83%
H:
1.35%
C:
1.2%
fda
for
car-t
U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
Published:
2024-04-18
(Crawled : 23:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
0.68%
|
O:
0.0%
H:
0.0%
C:
0.0%
entyvio
fda
disease
active
for
therapy
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch
Published:
2024-04-18
(Crawled : 14:00)
- biospace.com/
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
2.17%
|
O:
0.12%
H:
0.0%
C:
0.0%
fda
biosimilar
approval
for
stelara
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Published:
2024-04-16
(Crawled : 21:00)
- globenewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
1.96%
|
O:
-0.04%
H:
0.28%
C:
-0.16%
stelara
fda
biosimilar
approval
teva
Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil)
Published:
2024-04-16
(Crawled : 16:00)
- biospace.com/
PTPI
|
$0.6849
-1.86%
-1.9%
150K
|
|
-14.44%
|
O:
9.85%
H:
4.63%
C:
-18.04%
fda
positive
pharmaceuticals
for
technology
response
BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment
Published:
2024-04-16
(Crawled : 12:00)
- globenewswire.com
BRTX
|
$1.39
-3.47%
-3.6%
160K
|
Professional, Scientific, and T...
|
5.38%
|
O:
9.23%
H:
15.49%
C:
-7.75%
brtx-100
fda
clearance
study
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
Published:
2024-04-16
(Crawled : 12:00)
- globenewswire.com
LXEO
|
$11.995
-0.62%
-0.63%
87K
|
|
1.05%
|
O:
5.32%
H:
0.0%
C:
-2.63%
lx2006
fda
candidate
granted
treatment
designation
for
therapeutics
therapy
UroGen Announces FDA Acceptance of Investigational New Drug Application for UGN-103, a Next Generation Mitomycin-Based Formulation for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
Published:
2024-04-15
(Crawled : 13:00)
- biospace.com/
URGN
|
$13.78
-3.37%
-3.48%
390K
|
Health Technology
|
-9.07%
|
O:
1.46%
H:
1.17%
C:
-1.44%
ugn-103
fda
drug
bladder
cancer
for
application
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection
Published:
2024-04-15
(Crawled : 13:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
11.37%
|
O:
75.34%
H:
37.73%
C:
-30.58%
fda
drug
marburg
infection
designation
for
grants
Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia
Published:
2024-04-15
(Crawled : 13:00)
- globenewswire.com
RVPH
|
$3.035
0.5%
0.49%
140K
|
|
-18.16%
|
O:
-7.05%
H:
4.96%
C:
1.46%
fda
brilaroxazine
trials
for
schizophrenia
3D Systems Announces FDA Clearance for World’s First 3D-Printed PEEK Cranial Implants
Published:
2024-04-15
(Crawled : 13:00)
- globenewswire.com
DDD
F
|
$3.55
2.31%
0.0%
1.5M
|
Producer Manufacturing
|
-4.05%
|
O:
5.95%
H:
0.26%
C:
-9.95%
fda
first
clearance
for
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
Published:
2024-04-15
(Crawled : 13:00)
- globenewswire.com
RNAZ
|
$0.49
-2.39%
-2.45%
110K
|
Professional, Scientific, and T...
|
-22.74%
|
O:
0.11%
H:
5.95%
C:
-13.78%
mc138
fda
ttx-mc138
tumors
clearance
trial
therapeutics
advanced
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection
Published:
2024-04-11
(Crawled : 20:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-7.13%
|
O:
3.67%
H:
0.46%
C:
-19.02%
fda
drug
infection
designation
for
grants
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
Published:
2024-04-11
(Crawled : 13:00)
- globenewswire.com
CADL
|
$5.17
-5.31%
-5.61%
520K
|
|
1.37%
|
O:
25.49%
H:
23.75%
C:
13.75%
can-2409
fda
drug
cancer
pancreatic
treatment
designation
for
therapeutics
PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers
Published:
2024-04-11
(Crawled : 12:00)
- biospace.com/
PTCHF
|
$2.78
19.97%
560
|
n/a
|
-4.39%
|
O:
4.65%
H:
0.0%
C:
0.0%
lyt-200
fda
designation
for
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
Published:
2024-04-11
(Crawled : 12:00)
- biospace.com/
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
1.85%
|
O:
1.85%
H:
0.0%
C:
0.0%
biotech
fda
breast
cancer
for
meeting
trial
submission
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
Published:
2024-04-11
(Crawled : 05:00)
- globenewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-3.4%
|
O:
1.06%
H:
0.47%
C:
-0.03%
fda
device
disease
test
granted
blood
designation
for
alzheimer's
roche
Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit
Published:
2024-04-10
(Crawled : 12:00)
- biospace.com/
LH
M
|
$201.48
1.02%
0.0%
770K
|
Health Services
|
-4.55%
|
O:
-0.9%
H:
0.0%
C:
0.0%
fda
test
authorization
for
home
labcorp
Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Osteosarcoma
Published:
2024-04-09
(Crawled : 12:30)
- globenewswire.com
LSTA
|
$2.85
-5.82%
2K
|
Manufacturing
|
-6.9%
|
O:
0.34%
H:
9.62%
C:
3.78%
fda
drug
granted
treatment
designation
for
therapeutics
Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression
Published:
2024-04-09
(Crawled : 12:00)
- biospace.com/
SYRS
|
$4.54
-3.81%
-3.96%
260K
|
Health Technology
|
-2.16%
|
O:
2.16%
H:
23.21%
C:
16.03%
fda
treatment
designation
for
aml
← Previous
1
2
3
4
5
6
7
8
9
…
17
18
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.